Analyzing genetic mutations to improve cancer treatment
Mutational signature analysis: methods and applications to the clinic
This study is looking at how changes in genes can help us understand cancer better, so we can find personalized treatments that work best for each patient.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11075888 on NIH RePORTER |
What this research studies
This research focuses on developing advanced methods to analyze genetic mutations in cancer patients. By examining the patterns of these mutations, the team aims to identify specific 'signatures' that can provide insights into the biological processes affecting cancer. The project will utilize data from clinical cohorts to enhance the understanding of genomic instability and its implications for treatment, particularly in identifying biomarkers that can help tailor therapies for individual patients. The approach includes analyzing gene panel data, which is commonly used in clinical settings, to improve patient stratification and treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients undergoing genetic testing or those with known mutations such as BRCA1/2.
Not a fit: Patients without identifiable genetic mutations or those not diagnosed with cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual genetic profiles.
How similar studies have performed: Previous research has shown promising results in using mutational signature analysis to inform cancer treatment strategies, indicating a strong potential for success in this approach.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Park, Peter J — Harvard Medical School
- Study coordinator: Park, Peter J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.